Paperpal Prime Logo

Journal of Immunotherapy : Impact Factor & More

eISSN: 1537-4513pISSN: 1524-9557

Key Metrics

CiteScore
7.9
Eigenfactor
0.001 - 0.005
H-Index
103
Impact Factor
< 5
SJR
Q1Immunology
SNIP
0.8
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Immunotherapy

Journal of Immunotherapy Journal Specifications

Overview
Publisher LIPPINCOTT WILLIAMS & WILKINS
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year1991
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Immunotherapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Check your researchless than 30 sec
Free Report

Recently Published Papers in Journal of Immunotherapy

Identifying Patients at Risk for Immune Checkpoint Inhibitor-Induced Colitis: Evidence From a Real-World Oncology Cohort.
  • 1 Nov 2026
  • Journal of immunotherapy (Hagerstown, Md. : 1997)
Local Therapy for Isolated Residual Metastatic Melanoma and Renal Cell Carcinoma Following Immune Checkpoint Inhibition Leading to Long-Term Remission.
  • 1 Nov 2026
  • Journal of immunotherapy (Hagerstown, Md. : 1997)
Brief Communication: LSD1 Inhibition Enhances Susceptibility of Primary AML Cells for NK Cell-Mediated Killing.
  • 1 Nov 2026
  • Journal of immunotherapy (Hagerstown, Md. : 1997)
Auranofin Sensitizes Oral Squamous Cell Carcinoma to PD-1 Blockade Through DUSP1-Associated Macrophage Reprogramming.
  • 1 Nov 2026
  • Journal of immunotherapy (Hagerstown, Md. : 1997)
Immunostaining of p53 Is Associated With Efficacy of Anti-PD-1 Immune Checkpoint Inhibitors in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
  • 22 Oct 2026
  • Journal of immunotherapy (Hagerstown, Md. : 1997)
Area Deprivation Index and Survival Outcomes for Patients With Metastatic Solid Tumors Treated With Immune Checkpoint Inhibitors in the United States.
  • 20 Oct 2026
  • Journal of immunotherapy (Hagerstown, Md. : 1997)
Identifying Patients at Risk for Immune Checkpoint Inhibitor-Induced Colitis: Evidence From a Real-World Oncology Cohort.
  • 1 Nov 2026
  • Journal of immunotherapy (Hagerstown, Md. : 1997)
Local Therapy for Isolated Residual Metastatic Melanoma and Renal Cell Carcinoma Following Immune Checkpoint Inhibition Leading to Long-Term Remission.
  • 1 Nov 2026
  • Journal of immunotherapy (Hagerstown, Md. : 1997)
Brief Communication: LSD1 Inhibition Enhances Susceptibility of Primary AML Cells for NK Cell-Mediated Killing.
  • 1 Nov 2026
  • Journal of immunotherapy (Hagerstown, Md. : 1997)
Auranofin Sensitizes Oral Squamous Cell Carcinoma to PD-1 Blockade Through DUSP1-Associated Macrophage Reprogramming.
  • 1 Nov 2026
  • Journal of immunotherapy (Hagerstown, Md. : 1997)
Immunostaining of p53 Is Associated With Efficacy of Anti-PD-1 Immune Checkpoint Inhibitors in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma.
  • 22 Oct 2026
  • Journal of immunotherapy (Hagerstown, Md. : 1997)
Area Deprivation Index and Survival Outcomes for Patients With Metastatic Solid Tumors Treated With Immune Checkpoint Inhibitors in the United States.
  • 20 Oct 2026
  • Journal of immunotherapy (Hagerstown, Md. : 1997)
View all papers for this journal

FAQs on Journal of Immunotherapy

Global Journal Library:

Paperpal Prime logo

Cactus Communications Services Pte Ltd
20 McCallum Street, #19-01, Tokio Marine Centre, Singapore 069046

We are with you every step of the way as you achieve your dreams - publication, everything that precedes it, and everything that comes after. You are much more than your last research project. It’s time you got more.

Instagram icon

USEFUL LINKS

EXCITED ABOUT RESEARCHER.LIFE?

We are always looking for inspiration, feedback, and collaborators

Write to us

Copyright 2026 Cactus Communications. All rights reserved.

Privacy PolicyCookies PolicyTerms of UseCareers